A 13-year-old collaboration between Novo Nordisk and Emisphere Technologies now culminates in the acquisition of the latter by the former.
On Friday morning, Novo Nordisk announced that a final deal had been struck to take over the years-long collaborative partner, whose main asset is a technology which aids the formulation of drugs for oral ingestion – a delivery agent called Snac – which Novo Nordisk has employed in, for example, the development of semaglutide in tablet form, that is, the diabetes tablet Rybelsus.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Long wait for IVDR implementation is over, putting an end to pandemic "wild west"
After prolonged debates on potential bottlenecking and supply issues, the EU’s long-awaited In Vitro Diagnostic Medical Devices Regulation comes into force on May 26.
Bavarian Nordic upgrades guidance following vaccine contract
Bavarian has been the center of attention in recent days due to its monkeypox vaccine, and the company has now secured a vaccine contract with another undisclosed country. Consequently, Bavarian has raised its expectations for the full year.
US to start using Bavarian vaccine stockpile
In an attempt to contain a monkeypox outbreak, US authorities will start offering certain people Bavarian Nordic-developed Jynneos vaccinations against the infectious disease.
GN purchase story is very speculative, says analyst
Competition rules could block a purchase of GN Store Nord and subsequent divestment of GN Hearing, says a Sydbank analyst on the speculative story that this might be underway.
Novo Nordisk invests additional millions of dollars in new manufacturing facilities
Novo Nordisk’s DKK 17bn (USD 2.4bn) investment into upgrading and building new facilities in Kalundborg last year has now been followed by a DKK 1bn (USD 143.8m) investment in the same location.
IRT Manager, Clinical Drug Supply 
Director Global Engineering 
(Senior) Drug Substance Specialist 
Senior QA Specialist 
Clinical Trial Manager 
Senior Project Manager (GMP - Life Science) 
System Sales Development Consultant - Investment Projects, Merck Millipore 
Client Talent Acquisition Specialist 
Account Manager 
2 Sales Representatives and Product Specialists 
Cell Culture Scientist/Senior Scientist 
Innovation Project Manager, Display Unit 
Senior Chemical Safety Advisor 
SAP System Specialist (Product Supply) – Business Application Services 
KLIFO is looking for a Clinical Supply Manager for our Glostrup office 
Production Director 
CMO Operations Specialist - screening & selection of CMO/CDMO’s 
Project Manager & Scrum Master 
Nordic Medical Affairs Manager